Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new 'Study Status' section and revision metadata (Revision: v3.3.2) were added on 2025-11-24, while an older revision (v3.2.0) was deleted. No core study data or results were changed.SummaryDifference0.3%

- Check28 days agoChange DetectedThe government funding/operating status notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe new screenshot mirrors the old one, showing the same Version history and study details. Only minor UI/layout differences are visible between the two images. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange Detected- Added a Sponsor/Collaborators section to acknowledge partners. - No deletions observed; core content remains unchanged.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference9%

- Check78 days agoChange DetectedUpdated version to v3.1.0 with new date entries (2025-09-25, 2025-09-23) and study status; removed older revision reference v3.0.2 from 2025-09-05.SummaryDifference0.9%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.